AAAAAA
Results: 1-25/35
Authors:
Nguyen, MH
Wright, TL
Citation: Mh. Nguyen et Tl. Wright, Therapeutic advances in the management of hepatitis B and hepatitis C, CURR OPIN I, 14(5), 2001, pp. 593-601
Authors:
He, XS
Rehermann, B
Boisvert, J
Mumm, J
Maecker, HT
Roederer, M
Wright, TL
Maino, VC
Davis, MM
Greenberg, HB
Citation: Xs. He et al., Direct functional analysis of epitope-specific CD8+ T cells in peripheral blood, VIRAL IMMUN, 14(1), 2001, pp. 59-69
Authors:
Briggs, ME
Baker, C
Hall, R
Gaziano, JM
Gagnon, D
Bzowej, N
Wright, TL
Citation: Me. Briggs et al., Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration Medical Center, HEPATOLOGY, 34(6), 2001, pp. 1200-1205
Authors:
Orland, JR
Wright, TL
Cooper, S
Citation: Jr. Orland et al., Acute hepatitis C, HEPATOLOGY, 33(2), 2001, pp. 321-327
Authors:
Reddy, KR
Wright, TL
Pockros, PJ
Shiffman, M
Everson, G
Reindollar, R
Fried, MW
Purdum, PP
Jensen, D
Smith, C
Lee, WM
Boyer, TD
Lin, A
Pedder, S
DePamphilis, J
Citation: Kr. Reddy et al., Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared withinterferon alpha-2a in noncirrhotic patients with chronic hepatitis C, HEPATOLOGY, 33(2), 2001, pp. 433-438
Authors:
Berenguer, M
Lopez-Labrador, FX
Wright, TL
Citation: M. Berenguer et al., Hepatitis C and liver transplantation, J HEPATOL, 35(5), 2001, pp. 666-678
Authors:
Monto, A
Wright, TL
Citation: A. Monto et Tl. Wright, The epidemiology and prevention of hepatocellular carcinoma, SEMIN ONCOL, 28(5), 2001, pp. 441-449
Authors:
Ku, NO
Gish, R
Wright, TL
Omary, MB
Citation: No. Ku et al., Keratin 8 mutations in patients with cryptogenic liver disease., N ENG J MED, 344(21), 2001, pp. 1580-1587
Authors:
Spek, EJ
Wright, TL
Stitt, MS
Taghizadeh, NR
Tannenbaum, SR
Marinus, MG
Engelward, BP
Citation: Ej. Spek et al., Recombinational repair is critical for survival of Escherichia coli exposed to nitric oxide, J BACT, 183(1), 2001, pp. 131-138
Authors:
Zhuang, JC
Wright, TL
de Rojas-Walker, T
Tannenbaum, SR
Wogan, GN
Citation: Jc. Zhuang et al., HPRT mutation spectrum reporting - Response, ENV MOL MUT, 36(4), 2000, pp. 337-338
Authors:
Zhuang, JC
Wright, TL
deRojas-Walker, T
Tannenbaum, SR
Wogan, GN
Citation: Jc. Zhuang et al., Nitric oxide-induced mutations in the HPRT gene of human lymphoblastoid TK6 cells and in Salmonella typhimurium, ENV MOL MUT, 35(1), 2000, pp. 39-47
Authors:
Pessoa, MG
Berenguer, M
Wright, TL
Citation: Mg. Pessoa et al., Posttransplant hepatitis C virus quasispecies and cholestatic hepatitis - Reply, HEPATOLOGY, 32(5), 2000, pp. 1182-1182
Authors:
Berenguer, M
Lopez-Labrador, FX
Greenberg, HB
Wright, TL
Citation: M. Berenguer et al., Hepatitis C virus and the host: An imbalance induced by immunosuppression?, HEPATOLOGY, 32(2), 2000, pp. 433-435
Clinicopathological conference: Hepatitis C in a patient with human immunodeficiency virus infection
Authors:
Dove, LM
Alonzo, J
Wright, TL
Citation: Lm. Dove et al., Clinicopathological conference: Hepatitis C in a patient with human immunodeficiency virus infection, HEPATOLOGY, 32(1), 2000, pp. 147-152
Authors:
Hirsch, KR
Wright, TL
Citation: Kr. Hirsch et Tl. Wright, "Silent killer" or Benign disease? The dilemma of hepatitis C virus outcomes, HEPATOLOGY, 31(2), 2000, pp. 536-537
Authors:
Berenguer, M
Ferrell, L
Watson, J
Prieto, M
Kim, M
Rayon, M
Cordoba, J
Herola, A
Ascher, N
Mir, J
Berenguer, J
Wright, TL
Citation: M. Berenguer et al., HCV-related fibrosis progression following liver transplantation: increasein recent years, J HEPATOL, 32(4), 2000, pp. 673-684
Authors:
Heathcote, EJ
Shiffman, ML
Cooksley, WGE
Dusheiko, GM
Lee, SS
Balart, L
Reindollar, R
Reddy, RK
Wright, TL
Lin, A
Hoffman, J
De Pamphilis, J
Citation: Ej. Heathcote et al., Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis, N ENG J MED, 343(23), 2000, pp. 1673-1680
Authors:
Marnett, LJ
Wright, TL
Crews, BC
Tannenbaum, SR
Marrow, JD
Citation: Lj. Marnett et al., Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase, J BIOL CHEM, 275(18), 2000, pp. 13427-13430
Authors:
Saab, S
Kim, M
Wright, TL
Han, SHB
Martin, P
Busuttil, RW
Citation: S. Saab et al., Successful orthotopic liver transplantation for lamivudine-associated YMDDmutant hepatitis B virus, GASTROENTY, 119(5), 2000, pp. 1382-1384
The dilemma of disease progression in hepatitis C patients with normal serum aminotransferase levels
Authors:
Hirsch, KR
Wright, TL
Citation: Kr. Hirsch et Tl. Wright, The dilemma of disease progression in hepatitis C patients with normal serum aminotransferase levels, AM J MED, 109(1), 2000, pp. 66-67
Authors:
Fried, MW
Shiffman, M
Sterling, RK
Weinstein, J
Crippin, J
Garcia, G
Wright, TL
Conjeevaram, H
Reddy, KR
Peter, J
Cotsonis, GA
Nolte, FS
Citation: Mw. Fried et al., A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis C: Pretreatment stratification by viral burden and genotype, AM J GASTRO, 95(11), 2000, pp. 3225-3229
Authors:
Pessoa, MG
Wright, TL
Citation: Mg. Pessoa et Tl. Wright, Update on clinical trials in the treatment of hepatitis B, J GASTR HEP, 14, 1999, pp. S6-S11
Authors:
Bzowej, NH
Wright, TL
Citation: Nh. Bzowej et Tl. Wright, Viral hepatitis and liver transplantation, J GASTR HEP, 14, 1999, pp. S53-S60
Authors:
Pessoa, MG
Bzowej, N
Berenguer, M
Phung, Y
Kim, M
Ferrell, L
Hassoba, H
Wright, TL
Citation: Mg. Pessoa et al., Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation, HEPATOLOGY, 30(6), 1999, pp. 1513-1520
Authors:
Hassoba, HM
Bzowej, N
Berenguer, M
Kim, M
Zhou, S
Phung, Y
Grant, R
Pessoa, MG
Wright, TL
Citation: Hm. Hassoba et al., Evolution of viral quasispecies in interferon-treated patients with chronic hepatitis C virus infection, J HEPATOL, 31(4), 1999, pp. 618-627